
As an Amazon Associate and affiliate partner, Menrva Books earns from qualifying purchases. Learn more
This book was conceived from a simple question as to why cancer is so difficult to treat. Ultimately we want to find ways to cure cancers, but that may be an elusive dream at least with the technologies we have now and expect to have in the near future. This leads the question of whether it is possible to improve current cancer treatment methods, especially from the perspective of enhancing targeted drug delivery to tumors. This volume is designed to provide information related to the difficulties in treating cancers through targeted drug delivery, our current understanding of cancer biology, and potential technologies that might be used to achieve enhanced drug delivery to tumors. An ideal drug delivery system for treating cancers would maximize the therapeutic efficacy with minimal side effects in clinical applications. The seemingly improved anticancer efficacy of the current nanoparticle-based formulations needs to be viewed from the context of very poor success rates for translation to human applications. The results of in vitro cell culture models and small animal in vivo experiments have not been extrapolated to clinical applications. Finding the reasons for the lack of successful translation is required if we are to discover approaches to substantially extend the survival time of cancer patients, and hopefully identify cures. Cancer Targeted Drug Delivery: Elusive Dream describes some answers of achieving the so far elusive dream of treating cancers like other chronic diseases with therapies that focus using improved drug delivery systems designed to better align with the unique biological and physiological properties of cancer.
This book investigates the persistent challenges in treating cancer, particularly focusing on the complexities and potential of targeted drug delivery systems. The authors, experts in the field, explore the fundamental difficulties in eradicating cancer, the current understanding of cancer biology, and emerging technologies aimed at improving drug efficacy and minimizing side effects. It critically examines the translation gap between promising preclinical results and clinical applications, seeking to identify the reasons behind the limited success of nanoparticle-based formulations in human trials. The volume aims to provide insights into achieving the goal of treating cancer more effectively, akin to managing other chronic diseases, by better aligning therapeutic strategies with the unique biological characteristics of tumors.
The book addresses the critical challenge of improving cancer treatment through targeted drug delivery, a subject of significant interest in oncology and pharmaceutical research. It aims to bridge the gap between laboratory findings and clinical reality, highlighting the need for a deeper understanding of why many promising drug delivery systems fail in human applications. The authors' focus on aligning therapeutic strategies with cancer's unique biological properties suggests a comprehensive approach to developing more effective treatments. This work is positioned to inform researchers and clinicians on the current state and future directions in the pursuit of more successful cancer therapies.
Page Count:
720
Publication Date:
2013-08-31
Publisher:
Springer Nature
ISBN-10:
1461478766
ISBN-13:
9781461478768
No comments yet. Be the first to share your thoughts!